Literature DB >> 21508644

Midbrain atrophy in vascular Parkinsonism.

Seong-Min Choi1, Byeong C Kim, Tai-Seung Nam, Joon-Tae Kim, Seung-Han Lee, Man-Seok Park, Myeong-Kyu Kim, Mony J de Leon, Ki-Hyun Cho.   

Abstract

BACKGROUND: Midbrain atrophy is a well-known feature of progressive supranuclear palsy (PSP). Some clinical features of vascular parkinsonism (VP) such as pseudobulbar phenomena, lower body predominance and early postural instability suggest that the brainstem could be associated with VP. The aim of this study was to determine whether midbrain atrophy was present in patients with VP.
METHODS: We measured the midbrain (Amd) and pons area (Apn) of 20 patients with VP, 15 patients with probable PSP and 30 patients with idiopathic Parkinson's disease (IPD). The Amd and Apn were measured on mid-sagittal T(1)-weighted MRI scans using a computerized image analysis system.
RESULTS: For the Amd, the patients with VP (99.86 mm(2)) and PSP (87.30 mm(2)) had significantly smaller areas than the patients with IPD (130.52 mm(2)). For the Apn, there was a significant difference only between the VP (407.23 mm(2)) and the IPD (445.05 mm(2)) patients. The Amd/Apn ratios of the patients with VP (0.245) and PSP (0.208) were significantly smaller than in the patients with IPD (0.292).
CONCLUSIONS: Our study shows that brainstem atrophy often occurs in patients with VP and the midbrain is more vulnerable than the pons to atrophic changes.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21508644      PMCID: PMC3202929          DOI: 10.1159/000326907

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  24 in total

1.  Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy.

Authors:  M Warmuth-Metz; M Naumann; I Csoti; L Solymosi
Journal:  Arch Neurol       Date:  2001-07

Review 2.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

3.  Vascular parkinsonism: clinical correlates predicting motor improvement after lumbar puncture.

Authors:  William G Ondo; Ling Ling Chan; Joel K Levy
Journal:  Mov Disord       Date:  2002-01       Impact factor: 10.338

Review 4.  The neuropathology of progressive supranuclear palsy.

Authors:  P L Lantos
Journal:  J Neural Transm Suppl       Date:  1994

5.  Study of the rostral midbrain atrophy in progressive supranuclear palsy.

Authors:  Naoko Kato; Kimihito Arai; Takamichi Hattori
Journal:  J Neurol Sci       Date:  2003-06-15       Impact factor: 3.181

6.  Degeneration of the ipsilateral substantia nigra following cerebral infarction in the striatum.

Authors:  M Nakane; A Teraoka; R Asato; A Tamura
Journal:  Stroke       Date:  1992-03       Impact factor: 7.914

7.  Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis.

Authors:  Jan C M Zijlmans; Susan E Daniel; Andrew J Hughes; Tamas Révész; Andrew J Lees
Journal:  Mov Disord       Date:  2004-06       Impact factor: 10.338

8.  Midbrain atrophy in subcortical ischemic vascular dementia.

Authors:  Young-Hee Sung; Ki-Hyung Park; Yeung-Bae Lee; Hyeon-Mi Park; Dong Jin Shin; Jea-Sul Park; Mi-Sun Oh; Hyeo-Il Ma; Kyung-Ho Yu; Suk-Yun Kang; Yun Joong Kim; Byung-Chul Lee
Journal:  J Neurol       Date:  2009-12       Impact factor: 4.849

9.  Computed tomographic findings in progressive supranuclear palsy: correlation with clinical grade.

Authors:  S M Schonfeld; L I Golbe; J I Sage; J N Safer; R C Duvoisin
Journal:  Mov Disord       Date:  1987       Impact factor: 10.338

10.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

Authors:  F Fazekas; J B Chawluk; A Alavi; H I Hurtig; R A Zimmerman
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

View more
  7 in total

1.  MRI volumetric morphometry in vascular parkinsonism.

Authors:  Vincent Dunet; Jeremy Deverdun; Celine Charroud; Emmanuelle Le Bars; Francois Molino; Sophie Menjot de Champfleur; Florence Maury; Mahmoud Charif; Xavier Ayrignac; Pierre Labauge; Giovanni Castelnovo; Frederic Pinna; Alain Bonafe; Christian Geny; Nicolas Menjot de Champfleur
Journal:  J Neurol       Date:  2017-07-01       Impact factor: 4.849

2.  MRI measurements of brainstem structures in patients with vascular parkinsonism, progressive supranuclear palsy, and Parkinson's disease.

Authors:  Byeong C Kim; Seong-Min Choi; Kang-Ho Choi; Tai-Seung Nam; Joon-Tae Kim; Seung-Han Lee; Man-Seok Park; Woong Yoon
Journal:  Neurol Sci       Date:  2017-01-11       Impact factor: 3.307

3.  Magnetic resonance parkinsonism index in progressive supranuclear palsy and vascular parkinsonism.

Authors:  Giovanni Mostile; Alessandra Nicoletti; Calogero Edoardo Cicero; Tiziana Cavallaro; Elisa Bruno; Valeria Dibilio; Antonina Luca; Giorgia Sciacca; Loredana Raciti; Donatella Contrafatto; Ignazio Chiaramonte; Mario Zappia
Journal:  Neurol Sci       Date:  2016-01-28       Impact factor: 3.307

Review 4.  Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?

Authors:  Jennifer L Whitwell; Günter U Höglinger; Angelo Antonini; Yvette Bordelon; Adam L Boxer; Carlo Colosimo; Thilo van Eimeren; Lawrence I Golbe; Jan Kassubek; Carolin Kurz; Irene Litvan; Alexander Pantelyat; Gil Rabinovici; Gesine Respondek; Axel Rominger; James B Rowe; Maria Stamelou; Keith A Josephs
Journal:  Mov Disord       Date:  2017-05-13       Impact factor: 10.338

Review 5.  Vascular Parkinsonism and cognitive impairment: literature review, Brazilian studies and case vignettes.

Authors:  Thiago Cardoso Vale; Maira Tonidandel Barbosa; Paulo Caramelli; Francisco Cardoso
Journal:  Dement Neuropsychol       Date:  2012 Jul-Sep

Review 6.  Neuroimaging in Vascular Parkinsonism.

Authors:  Karen K Y Ma; Shi Lin; Vincent C T Mok
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-26       Impact factor: 5.081

7.  Midbrain atrophy related to parkinsonism in a non-coding repeat expansion disorder: five cases of spinocerebellar ataxia type 31 with nigrostriatal dopaminergic dysfunction.

Authors:  Ryohei Norioka; Keizo Sugaya; Aki Murayama; Tomoya Kawazoe; Shinsuke Tobisawa; Akihiro Kawata; Kazushi Takahashi
Journal:  Cerebellum Ataxias       Date:  2021-03-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.